Neoadjuvant Treatments for Locally Advanced, Resectable Esophageal Cancer: A Network Meta-Analysis

International Journal of Cancer - United States
doi 10.1002/ijc.31312
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Neoadjuvant Treatment Strategy for Locally Advanced Thoracic Esophageal Cancer

Annals of Gastroenterological Surgery
2019English

Folfirinox Neoadjuvant Therapy for Locally Advanced and Borderline Resectable Pancreatic Cancer - A Retrospective Study

International Journal of Contemporary Medical Research [IJCMR]
2019English

Neoadjuvant FOLFIRINOX for Patients With Borderline Resectable or Locally Advanced Pancreatic Cancer: Results of a Decision Analysis

Oncologist
Cancer ResearchMedicineOncology
2019English

Neoadjuvant Therapy for Resectable and Borderline Resectable Pancreatic Cancer: A Meta-Analysis of Randomized Controlled Trials

Journal of Clinical Medicine
2020English

Neoadjuvant Chemotherapy of Resectable Advanced Gastric Cancer

Nihon Gekakei Rengo Gakkaishi (Journal of Japanese College of Surgeons)
2012English

A Meta-Analysis of Concurrent Chemoradiotherapy for Advanced Esophageal Cancer

PLoS ONE
Multidisciplinary
2015English

Neoadjuvant Treatment Strategies for Locally Advanced Rectal Cancer

Clinical Oncology
Nuclear MedicineRadiologyImagingOncology
2016English

Neoadjuvant Crizotinib in Resectable Locally Advanced Non-Small-Cell Lung Cancer With ALK-rearrangement: A Brief Report

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2019English

Clinical Benefit of Adding Oxaliplatin to Standard Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer: A Meta-Analysis

BMC Cancer
Cancer ResearchOncologyGenetics
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy